APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Dermatological Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prescription Dermatological Drugs Industry Growth and Trends Forecast to 2032

27 December 2025104 pages

Choose your research edition.

Industry ResearchPrescription Dermatological Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Dermatological Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Prescription Dermatological Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Dermatological Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Dermatological Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Prescription Dermatological Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prescription Dermatological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prescription Dermatological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Dermatological Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prescription Dermatological Drugs include Johnson & Johnson, Merck, Mylan Pharmaceuticals, Roche, Pfizer, PharmaDerm Pharmaceuticals, LEO Pharma, Bausch Health and Allergan Inamed Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prescription Dermatological Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prescription Dermatological Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prescription Dermatological Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prescription Dermatological Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prescription Dermatological Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prescription Dermatological Drugs Market by Company

Johnson & Johnson

Merck

Mylan Pharmaceuticals

Roche

Pfizer

PharmaDerm Pharmaceuticals

LEO Pharma

Bausch Health

Allergan Inamed Corporation

Allergan

Prescription Dermatological Drugs Segment by Type

Melasma Drugs

Anti-acne Drugs

Anti-aging Drugs

Skin Cancer Drugs

Dermatitis Drugs

Hair Loss Drugs

Psoriasis Drugs

Seborrhea Drugs

Prescription Dermatological Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Prescription Dermatological Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Dermatological Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Dermatological Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Dermatological Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prescription Dermatological Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prescription Dermatological Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Melasma Drugs Table 2. Major Company of Anti-acne Drugs Table 3. Major Company of Anti-aging Drugs Table 4. Major Company of Skin Cancer Drugs Table 5. Major Company of Dermatitis Drugs Table 6. Major Company of Hair Loss Drugs Table 7. Major Company of Psoriasis Drugs Table 8. Major Company of Seborrhea Drugs Table 9. Global Prescription Dermatological Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global Prescription Dermatological Drugs Sales by Type (2021-2026) & (W Units) Table 11. Global Prescription Dermatological Drugs Sales Market Share in Volume by Type (2021-2026) Table 12. Global Prescription Dermatological Drugs Sales by Type (2021-2026) & (US$ Million) Table 13. Global Prescription Dermatological Drugs Sales Market Share in Value by Type (2021-2026) Table 14. Global Prescription Dermatological Drugs Price by Type (2021-2026) & (US$/Unit) Table 15. Global Prescription Dermatological Drugs Sales by Type (2027-2032) & (W Units) Table 16. Global Prescription Dermatological Drugs Sales Market Share in Volume by Type (2027-2032) Table 17. Global Prescription Dermatological Drugs Sales by Type (2027-2032) & (US$ Million) Table 18. Global Prescription Dermatological Drugs Sales Market Share in Value by Type (2027-2032) Table 19. Global Prescription Dermatological Drugs Price by Type (2027-2032) & (US$/Unit) Table 20. North America Prescription Dermatological Drugs Sales by Type (2021-2026) & (W Units) Table 21. North America Prescription Dermatological Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Europe Prescription Dermatological Drugs Sales by Type (2021-2026) & (W Units) Table 23. Europe Prescription Dermatological Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific Prescription Dermatological Drugs Sales by Type (2021-2026) & (W Units) Table 25. Asia-Pacific Prescription Dermatological Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America Prescription Dermatological Drugs Sales by Type (2021-2026) & (W Units) Table 27. Latin America Prescription Dermatological Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2021-2026) & (W Units) Table 29. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2021-2026) & (US$ Million) Table 30. Prescription Dermatological Drugs Industry Trends Table 31. Prescription Dermatological Drugs Industry Drivers Table 32. Prescription Dermatological Drugs Industry Opportunities and Challenges Table 33. Prescription Dermatological Drugs Industry Restraints Table 34. Global Prescription Dermatological Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global Prescription Dermatological Drugs Revenue Market Share by Company (2021-2026) Table 36. Global Prescription Dermatological Drugs Sales by Company (2021-2026) & (W Units) Table 37. Global Prescription Dermatological Drugs Sales Share by Company (2021-2026) Table 38. Global Prescription Dermatological Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 39. Global Prescription Dermatological Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global Prescription Dermatological Drugs Major Company Production Sites and Headquarters Table 41. Global Prescription Dermatological Drugs Company, Product Type & Application Table 42. Global Prescription Dermatological Drugs Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global Prescription Dermatological Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global Prescription Dermatological Drugs Sales by Region (2021-2026) & (W Units) Table 47. Global Prescription Dermatological Drugs Sales Market Share in Volume by Region (2021-2026) Table 48. Global Prescription Dermatological Drugs Sales by Region (2021-2026) & (US$ Million) Table 49. Global Prescription Dermatological Drugs Sales Market Share in Value by Region (2021-2026) Table 50. Global Prescription Dermatological Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Global Prescription Dermatological Drugs Sales by Region (2027-2032) & (W Units) Table 52. Global Prescription Dermatological Drugs Sales Market Share in Volume by Region (2027-2032) Table 53. Global Prescription Dermatological Drugs Sales by Region (2027-2032) & (US$ Million) Table 54. Global Prescription Dermatological Drugs Sales Market Share in Value by Region (2027-2032) Table 55. Global Prescription Dermatological Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 56. Global Prescription Dermatological Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global Prescription Dermatological Drugs Sales by Application (2021-2026) & (W Units) Table 58. Global Prescription Dermatological Drugs Sales Market Share in Volume by Application (2021-2026) Table 59. Global Prescription Dermatological Drugs Sales by Application (2021-2026) & (US$ Million) Table 60. Global Prescription Dermatological Drugs Sales Market Share in Value by Application (2021-2026) Table 61. Global Prescription Dermatological Drugs Price by Application (2021-2026) & (US$/Unit) Table 62. Global Prescription Dermatological Drugs Sales by Application (2027-2032) & (W Units) Table 63. Global Prescription Dermatological Drugs Sales Market Share in Volume by Application (2027-2032) Table 64. Global Prescription Dermatological Drugs Sales by Application (2027-2032) & (US$ Million) Table 65. Global Prescription Dermatological Drugs Sales Market Share in Value by Application (2027-2032) Table 66. Global Prescription Dermatological Drugs Price by Application (2027-2032) & (US$/Unit) Table 67. North America Prescription Dermatological Drugs Sales by Application (2021-2026) & (W Units) Table 68. North America Prescription Dermatological Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Europe Prescription Dermatological Drugs Sales by Application (2021-2026) & (W Units) Table 70. Europe Prescription Dermatological Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific Prescription Dermatological Drugs Sales by Application (2021-2026) & (W Units) Table 72. Asia-Pacific Prescription Dermatological Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America Prescription Dermatological Drugs Sales by Application (2021-2026) & (W Units) Table 74. Latin America Prescription Dermatological Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2021-2026) & (W Units) Table 76. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2021-2026) & (US$ Million) Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Prescription Dermatological Drugs Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck Prescription Dermatological Drugs Product Portfolio Table 86. Merck Recent Development Table 87. Mylan Pharmaceuticals Company Information Table 88. Mylan Pharmaceuticals Business Overview Table 89. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mylan Pharmaceuticals Prescription Dermatological Drugs Product Portfolio Table 91. Mylan Pharmaceuticals Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Roche Prescription Dermatological Drugs Product Portfolio Table 96. Roche Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pfizer Prescription Dermatological Drugs Product Portfolio Table 101. Pfizer Recent Development Table 102. PharmaDerm Pharmaceuticals Company Information Table 103. PharmaDerm Pharmaceuticals Business Overview Table 104. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Portfolio Table 106. PharmaDerm Pharmaceuticals Recent Development Table 107. LEO Pharma Company Information Table 108. LEO Pharma Business Overview Table 109. LEO Pharma Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. LEO Pharma Prescription Dermatological Drugs Product Portfolio Table 111. LEO Pharma Recent Development Table 112. Bausch Health Company Information Table 113. Bausch Health Business Overview Table 114. Bausch Health Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Bausch Health Prescription Dermatological Drugs Product Portfolio Table 116. Bausch Health Recent Development Table 117. Allergan Inamed Corporation Company Information Table 118. Allergan Inamed Corporation Business Overview Table 119. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Allergan Inamed Corporation Prescription Dermatological Drugs Product Portfolio Table 121. Allergan Inamed Corporation Recent Development Table 122. Allergan Company Information Table 123. Allergan Business Overview Table 124. Allergan Prescription Dermatological Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Allergan Prescription Dermatological Drugs Product Portfolio Table 126. Allergan Recent Development Table 127. North America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 128. North America Prescription Dermatological Drugs Sales by Country (2021-2026) & (W Units) Table 129. North America Prescription Dermatological Drugs Sales Market Share by Country (2021-2026) Table 130. North America Prescription Dermatological Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 131. North America Prescription Dermatological Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. North America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Prescription Dermatological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Prescription Dermatological Drugs Market Share by Country (2021-2026) Table 135. North America Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Prescription Dermatological Drugs Market Share Forecast by Country (2027-2032) Table 137. Europe Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 138. Europe Prescription Dermatological Drugs Sales by Country (2021-2026) & (W Units) Table 139. Europe Prescription Dermatological Drugs Sales Market Share by Country (2021-2026) Table 140. Europe Prescription Dermatological Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 141. Europe Prescription Dermatological Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Prescription Dermatological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Prescription Dermatological Drugs Market Share by Country (2021-2026) Table 145. Europe Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Prescription Dermatological Drugs Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Prescription Dermatological Drugs Sales by Country (2021-2026) & (W Units) Table 149. Asia-Pacific Prescription Dermatological Drugs Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Prescription Dermatological Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 151. Asia-Pacific Prescription Dermatological Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Prescription Dermatological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Prescription Dermatological Drugs Market Share by Country (2021-2026) Table 155. Asia-Pacific Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Prescription Dermatological Drugs Market Share Forecast by Country (2027-2032) Table 157. Latin America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 158. Latin America Prescription Dermatological Drugs Sales by Country (2021-2026) & (W Units) Table 159. Latin America Prescription Dermatological Drugs Sales Market Share by Country (2021-2026) Table 160. Latin America Prescription Dermatological Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 161. Latin America Prescription Dermatological Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Prescription Dermatological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Prescription Dermatological Drugs Market Share by Country (2021-2026) Table 165. Latin America Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Prescription Dermatological Drugs Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2021-2026) & (W Units) Table 169. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Prescription Dermatological Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 171. Middle East and Africa Prescription Dermatological Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Prescription Dermatological Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Prescription Dermatological Drugs Market Share by Country (2021-2026) Table 175. Middle East and Africa Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Prescription Dermatological Drugs Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Prescription Dermatological Drugs Distributors List Table 180. Prescription Dermatological Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Prescription Dermatological Drugs Image Figure 2. Global Prescription Dermatological Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Dermatological Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Prescription Dermatological Drugs Sales (2021-2032) & (W Units) Figure 5. Melasma Drugs Image Figure 6. Global Melasma Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 7. Anti-acne Drugs Image Figure 8. Global Anti-acne Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 9. Anti-aging Drugs Image Figure 10. Global Anti-aging Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 11. Skin Cancer Drugs Image Figure 12. Global Skin Cancer Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 13. Dermatitis Drugs Image Figure 14. Global Dermatitis Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 15. Hair Loss Drugs Image Figure 16. Global Hair Loss Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 17. Psoriasis Drugs Image Figure 18. Global Psoriasis Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 19. Seborrhea Drugs Image Figure 20. Global Seborrhea Drugs Sales YoY Growth (2021-2032) & (W Units) Figure 21. Global Prescription Dermatological Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global Prescription Dermatological Drugs Market Share by Type 2025 VS 2032 Figure 23. North America Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2025 Figure 24. North America Prescription Dermatological Drugs Sales Market Share in Value by Type in 2025 Figure 25. Europe Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Europe Prescription Dermatological Drugs Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Value by Type in 2025 Figure 29. Latin America Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Latin America Prescription Dermatological Drugs Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 Prescription Dermatological Drugs Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Hospital Pharmacies Image Figure 36. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (W Units) Figure 37. Online Pharmacies Image Figure 38. Global Online Pharmacies Sales YoY Growth (2021-2032) & (W Units) Figure 39. Retail Pharmacies Image Figure 40. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (W Units) Figure 41. Global Prescription Dermatological Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Prescription Dermatological Drugs Market Share by Application 2025 VS 2032 Figure 43. North America Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2025 Figure 44. North America Prescription Dermatological Drugs Sales Market Share in Value by Application in 2025 Figure 45. Europe Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Europe Prescription Dermatological Drugs Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Prescription Dermatological Drugs Sales Market Share in Value by Application in 2025 Figure 49. Latin America Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Prescription Dermatological Drugs Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Prescription Dermatological Drugs Sales Market Share in Value by Application in 2025 Figure 53. North America Prescription Dermatological Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. North America Prescription Dermatological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Prescription Dermatological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Prescription Dermatological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Prescription Dermatological Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Europe Prescription Dermatological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Prescription Dermatological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Prescription Dermatological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Prescription Dermatological Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Asia-Pacific Prescription Dermatological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Prescription Dermatological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Prescription Dermatological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Prescription Dermatological Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Latin America Prescription Dermatological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Prescription Dermatological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Prescription Dermatological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Prescription Dermatological Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 70. Middle East and Africa Prescription Dermatological Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Prescription Dermatological Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Prescription Dermatological Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Prescription Dermatological Drugs Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Prescription Dermatological Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Melasma Drugs
  • Anti-acne Drugs
  • Anti-aging Drugs
  • Skin Cancer Drugs
  • Dermatitis Drugs
  • Hair Loss Drugs
  • Psoriasis Drugs
  • Seborrhea Drugs
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Johnson & Johnson
  • Merck
  • Mylan Pharmaceuticals
  • Roche
  • Pfizer
  • PharmaDerm Pharmaceuticals
  • LEO Pharma
  • Bausch Health
  • Allergan Inamed Corporation
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prescription Dermatological Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prescription Dermatological Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prescription Dermatological Drugs Market by Type
  6. 1.3.1 Melasma Drugs
  7. 1.3.2 Anti-acne Drugs
  8. 1.3.3 Anti-aging Drugs
  9. 1.3.4 Skin Cancer Drugs
  10. 1.3.5 Dermatitis Drugs
  11. 1.3.6 Hair Loss Drugs
  12. 1.3.7 Psoriasis Drugs
  13. 1.3.8 Seborrhea Drugs
  14. 1.4 Global Prescription Dermatological Drugs Market Size by Type
  15. 1.4.1 Global Prescription Dermatological Drugs Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global Prescription Dermatological Drugs Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global Prescription Dermatological Drugs Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America Prescription Dermatological Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe Prescription Dermatological Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific Prescription Dermatological Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America Prescription Dermatological Drugs Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa Prescription Dermatological Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prescription Dermatological Drugs Industry Trends
  2. 2.2 Prescription Dermatological Drugs Industry Drivers
  3. 2.3 Prescription Dermatological Drugs Industry Opportunities and Challenges
  4. 2.4 Prescription Dermatological Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prescription Dermatological Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Prescription Dermatological Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Prescription Dermatological Drugs Price (2021-2026)
  4. 3.4 Global Prescription Dermatological Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prescription Dermatological Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Prescription Dermatological Drugs Company, Product Type & Application
  7. 3.7 Global Prescription Dermatological Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prescription Dermatological Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prescription Dermatological Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prescription Dermatological Drugs Tier 1, Tier 2, and Tier 3
4 Prescription Dermatological Drugs Regional Status and Outlook
  1. 4.1 Global Prescription Dermatological Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prescription Dermatological Drugs Historic Market Size by Region
  3. 4.2.1 Global Prescription Dermatological Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prescription Dermatological Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prescription Dermatological Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prescription Dermatological Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Prescription Dermatological Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prescription Dermatological Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prescription Dermatological Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prescription Dermatological Drugs by Application
  1. 5.1 Prescription Dermatological Drugs Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Prescription Dermatological Drugs Market Size by Application
  6. 5.2.1 Global Prescription Dermatological Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prescription Dermatological Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prescription Dermatological Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prescription Dermatological Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prescription Dermatological Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prescription Dermatological Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prescription Dermatological Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prescription Dermatological Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Prescription Dermatological Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Prescription Dermatological Drugs Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Mylan Pharmaceuticals
  14. 6.3.1 Mylan Pharmaceuticals Company Information
  15. 6.3.2 Mylan Pharmaceuticals Business Overview
  16. 6.3.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Product Portfolio
  18. 6.3.5 Mylan Pharmaceuticals Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Prescription Dermatological Drugs Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Prescription Dermatological Drugs Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 PharmaDerm Pharmaceuticals
  32. 6.6.1 PharmaDerm Pharmaceuticals Company Information
  33. 6.6.2 PharmaDerm Pharmaceuticals Business Overview
  34. 6.6.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Portfolio
  36. 6.6.5 PharmaDerm Pharmaceuticals Recent Developments
  37. 6.7 LEO Pharma
  38. 6.7.1 LEO Pharma Company Information
  39. 6.7.2 LEO Pharma Business Overview
  40. 6.7.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 LEO Pharma Prescription Dermatological Drugs Product Portfolio
  42. 6.7.5 LEO Pharma Recent Developments
  43. 6.8 Bausch Health
  44. 6.8.1 Bausch Health Company Information
  45. 6.8.2 Bausch Health Business Overview
  46. 6.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bausch Health Prescription Dermatological Drugs Product Portfolio
  48. 6.8.5 Bausch Health Recent Developments
  49. 6.9 Allergan Inamed Corporation
  50. 6.9.1 Allergan Inamed Corporation Company Information
  51. 6.9.2 Allergan Inamed Corporation Business Overview
  52. 6.9.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Allergan Inamed Corporation Prescription Dermatological Drugs Product Portfolio
  54. 6.9.5 Allergan Inamed Corporation Recent Developments
  55. 6.10 Allergan
  56. 6.10.1 Allergan Company Information
  57. 6.10.2 Allergan Business Overview
  58. 6.10.3 Allergan Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Allergan Prescription Dermatological Drugs Product Portfolio
  60. 6.10.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Prescription Dermatological Drugs Sales by Country
  2. 7.1.1 North America Prescription Dermatological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prescription Dermatological Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Prescription Dermatological Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prescription Dermatological Drugs Market Size by Country
  6. 7.2.1 North America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prescription Dermatological Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prescription Dermatological Drugs Sales by Country
  2. 8.1.1 Europe Prescription Dermatological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prescription Dermatological Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Prescription Dermatological Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prescription Dermatological Drugs Market Size by Country
  6. 8.2.1 Europe Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prescription Dermatological Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prescription Dermatological Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Prescription Dermatological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prescription Dermatological Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prescription Dermatological Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prescription Dermatological Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prescription Dermatological Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prescription Dermatological Drugs Sales by Country
  2. 10.1.1 South America Prescription Dermatological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prescription Dermatological Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Prescription Dermatological Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prescription Dermatological Drugs Market Size by Country
  6. 10.2.1 South America Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prescription Dermatological Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Prescription Dermatological Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prescription Dermatological Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prescription Dermatological Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prescription Dermatological Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Prescription Dermatological Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prescription Dermatological Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prescription Dermatological Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prescription Dermatological Drugs Value Chain Analysis
  2. 12.1.1 Prescription Dermatological Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prescription Dermatological Drugs Production Mode & Process
  7. 12.2 Prescription Dermatological Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prescription Dermatological Drugs Distributors
  10. 12.2.3 Prescription Dermatological Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst